arginine and Akinetic-Rigid Variant of Huntington Disease

arginine has been researched along with Akinetic-Rigid Variant of Huntington Disease in 17 studies

Research

Studies (17)

TimeframeStudies, this research(%)All Research%
pre-19905 (29.41)18.7374
1990's0 (0.00)18.2507
2000's4 (23.53)29.6817
2010's4 (23.53)24.3611
2020's4 (23.53)2.80

Authors

AuthorsStudies
Chighladze, E; Cole, RN; Faragó, A; Jiang, M; Jin, J; Kamath, SV; O'Meally, RN; Ratovitski, T; Rauniyar, P; Ross, CA; Shevelkin, AV1
Adachi, H; Fujita, H; Ito, C; Katsuno, M; Minakawa, EN; Mochizuki, H; Nagai, Y; Okamoto, Y; Onodera, O; Ozawa, D; Popiel, HA; Saito, Y; Saitoh, Y; Shiraki, K; Sobue, G; Suzuki, M; Tada, M; Takahashi, T; Takahashi, Y; Takeda, A; Takeuchi, T; Toda, T; Wada, K; Watase, K; Yagihara, H; Yamamoto, K; Yamane, H1
Ferraro, TN; Gaughan, J; Hackmyer, C; Khadeer, M; Lovett, J; McGarry, A; Moaddel, R; Pradhan, B; Shaikh, H; Wainer, IW1
Anderson, EN; Basso, M; Caricasole, A; Grant, RA; Hernández, IH; Lucas, JJ; Migazzi, A; Pandey, UB; Pennuto, M; Ratovitski, T; Roccuzzo, M; Ross, CA; Saudou, F; Scaramuzzino, C; Tosatto, L; Tripathy, D; Virlogeux, A; Zuccato, C1
Amaral, M; Giorgini, F; Heyes, DJ; Lafite, P; Levy, C; Leys, D; Outeiro, TF; Scrutton, NS1
Arbez, N; Chighladze, E; Ratovitski, T; Ross, CA; Stewart, JC1
Bawden, CS; Fraser, CK; Kuchel, TR; Middleton, B; Morton, AJ; Pennings, JL; Rudiger, SR; Skene, DJ1
Colao, A; De Michele, G; Di Maio, L; Di Somma, C; Filla, A; Lombardi, G; Rinaldi, C; Salvatore, E; Savastano, S; Tucci, T1
Baksi, K; Bhattacharyya, NP; Chattopadhyay, B; Mukhopadhyay, S1
Duan, W; Jiang, M; Li, Q; Liang, Y; Masuda, N; Peng, Q; Ross, CA; Wang, W; Wang, X; Zhao, M1
Destée, A; Fossati, P; Petit, H; Warot, P1
Abeles, I; Covault, J; Deckel, AW; Gary, KA; Sasso, D; Schmerler, N; Volmer, P; Watts, D; Weiner, R; Yan, Z1
Deckel, AW1
Leopold, NA; Podolsky, S2
Leopold, NA; Podolsky, S; Sax, DS1
Oepen, H; Oepen, I; Pape, C1

Reviews

1 review(s) available for arginine and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Nitric oxide and nitric oxide synthase in Huntington's disease.
    Journal of neuroscience research, 2001, Apr-15, Volume: 64, Issue:2

    Topics: Animals; Apoptosis; Arginine; Calmodulin; Caspases; Cerebrovascular Circulation; CREB-Binding Protein; Enzyme Activation; Enzyme Induction; Forecasting; Glutamic Acid; Humans; Huntington Disease; Mice; Mice, Transgenic; Mitochondria; Models, Animal; Models, Neurological; Nerve Tissue Proteins; Neurons; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Nuclear Proteins; Oxidative Stress; Proto-Oncogene Proteins p21(ras); RNA, Messenger; Trans-Activators

2001

Other Studies

16 other study(ies) available for arginine and Akinetic-Rigid Variant of Huntington Disease

ArticleYear
Interaction of huntingtin with PRMTs and its subsequent arginine methylation affects HTT solubility, phase transition behavior and neuronal toxicity.
    Human molecular genetics, 2022, 05-19, Volume: 31, Issue:10

    Topics: Animals; Arginine; Humans; Huntingtin Protein; Huntington Disease; Methylation; Mice; Nuclear Proteins; Protein Processing, Post-Translational; Protein-Arginine N-Methyltransferases; Solubility

2022
Arginine is a disease modifier for polyQ disease models that stabilizes polyQ protein conformation.
    Brain : a journal of neurology, 2020, 06-01, Volume: 143, Issue:6

    Topics: Animals; Arginine; Caenorhabditis elegans; Disease Models, Animal; Drosophila; Female; Heredodegenerative Disorders, Nervous System; Huntington Disease; Male; Mice; Mice, Inbred Strains; Molecular Chaperones; Peptides; Protein Aggregation, Pathological; Protein Conformation; Protein Folding; Spinocerebellar Ataxias

2020
Cross-sectional analysis of plasma and CSF metabolomic markers in Huntington's disease for participants of varying functional disability: a pilot study.
    Scientific reports, 2020, 11-24, Volume: 10, Issue:1

    Topics: Adult; Arginine; Biomarkers; Creatine; Cross-Sectional Studies; Disability Evaluation; Female; Glycine; Humans; Huntington Disease; Male; Metabolomics; Middle Aged; Pilot Projects; Treatment Outcome; Young Adult

2020
Huntingtin-mediated axonal transport requires arginine methylation by PRMT6.
    Cell reports, 2021, 04-13, Volume: 35, Issue:2

    Topics: Amino Acid Sequence; Animals; Arginine; Axonal Transport; Brain-Derived Neurotrophic Factor; Cell Death; Disease Models, Animal; Drosophila melanogaster; Epigenesis, Genetic; Genes, Reporter; Green Fluorescent Proteins; HEK293 Cells; Humans; Huntingtin Protein; Huntington Disease; Methylation; Mice; Mice, Transgenic; Neuromuscular Junction; Neurons; Nuclear Proteins; Protein Isoforms; Protein-Arginine N-Methyltransferases; Transport Vesicles

2021
Structural basis of kynurenine 3-monooxygenase inhibition.
    Nature, 2013, Apr-18, Volume: 496, Issue:7445

    Topics: Arginine; Blood-Brain Barrier; Catalytic Domain; Crystallography, X-Ray; Cyclopropanes; Drug Design; Enzyme Inhibitors; Humans; Huntington Disease; Kynurenine; Kynurenine 3-Monooxygenase; Models, Molecular; Molecular Targeted Therapy; Protein Conformation; Reproducibility of Results; Saccharomyces cerevisiae; Structure-Activity Relationship

2013
PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
    Cell cycle (Georgetown, Tex.), 2015, Volume: 14, Issue:11

    Topics: Animals; Arginine; Blotting, Western; Brain; Epigenesis, Genetic; Gene Expression Regulation; HEK293 Cells; Humans; Huntingtin Protein; Huntington Disease; Mice; Microscopy, Fluorescence; Nerve Tissue Proteins; Nuclear Proteins; Protein-Arginine N-Methyltransferases; Rats

2015
Metabolic profiling of presymptomatic Huntington's disease sheep reveals novel biomarkers.
    Scientific reports, 2017, 02-22, Volume: 7

    Topics: Amino Acids, Branched-Chain; Animals; Animals, Genetically Modified; Area Under Curve; Arginine; Biomarkers; Citrulline; Genotype; Huntington Disease; Logistic Models; Metabolomics; ROC Curve; Sheep

2017
Growth hormone response to arginine test differentiates between two subgroups of Huntington's disease patients.
    Journal of neurology, neurosurgery, and psychiatry, 2011, Volume: 82, Issue:5

    Topics: Adult; Aged; Arginine; Case-Control Studies; Cholesterol, HDL; Cholesterol, LDL; Female; Human Growth Hormone; Humans; Huntington Disease; Insulin; Insulin-Like Growth Factor I; Male; Middle Aged; Severity of Illness Index

2011
Modulation of age at onset of Huntington disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes.
    Neuroscience letters, 2005, Feb-10, Volume: 374, Issue:2

    Topics: Adolescent; Adult; Age of Onset; Aged; Aged, 80 and over; Arginine; Deoxyribonucleases; Female; Genetic Variation; Genotype; Glucan 1,3-beta-Glucosidase; Humans; Huntington Disease; Lysine; Male; Odds Ratio; Poly-ADP-Ribose Binding Proteins; Polymorphism, Single Nucleotide; Proline; Trinucleotide Repeat Expansion; Tumor Suppressor Protein p53

2005
Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease.
    Neurobiology of disease, 2008, Volume: 30, Issue:3

    Topics: Animals; Arginine; Asparagine; Disease Models, Animal; Female; Glutamine; Huntington Disease; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Neurologic Mutants; Mice, Transgenic; Neuroprotective Agents; Nipecotic Acids; PC12 Cells; Rats; Tiagabine

2008
[Huntington's chorea and somatotropic hormone: dynamic explorations in 27 cases (author's transl)].
    Revue neurologique, 1981, Volume: 137, Issue:1

    Topics: Adolescent; Adult; Arginine; Bromocriptine; Female; Glucose Tolerance Test; Growth Hormone; Humans; Huntington Disease; Levodopa; Male; Middle Aged; Receptors, Dopamine; Stimulation, Chemical; Time Factors

1981
Dietary arginine alters time of symptom onset in Huntington's disease transgenic mice.
    Brain research, 2000, Sep-01, Volume: 875, Issue:1-2

    Topics: Animals; Arginine; Blood Glucose; Brain; Cerebrovascular Circulation; Diet; Huntington Disease; Mice; Mice, Transgenic; Movement Disorders; Time Factors; Tyrosine; Weight Loss

2000
Exaggerated growth hormone response to arginine infusion in Huntington's disease.
    The Journal of clinical endocrinology and metabolism, 1975, Volume: 41, Issue:1

    Topics: Adult; Aged; Arginine; Glucose Tolerance Test; Growth Hormone; Humans; Huntington Disease; Insulin; Kinetics; Male; Middle Aged; Stimulation, Chemical

1975
Abnormal glucose tolerance and arginine tolerance tests in Huntington's disease.
    Gerontology, 1977, Volume: 23, Issue:1

    Topics: Adult; Aged; Arginine; Diabetic Neuropathies; Female; Glucose Tolerance Test; Growth Hormone; Humans; Huntington Disease; Insulin; Male; Middle Aged

1977
Increased frequency of diabetes mellitus in patients with Huntington's chorea.
    Lancet (London, England), 1972, Jun-24, Volume: 1, Issue:7765

    Topics: Acidosis; Adult; Aged; Arginine; Blood Glucose; Diabetes Complications; Diabetes Mellitus; Fasting; Glucose Tolerance Test; Glycosuria; Humans; Huntington Disease; Hyperglycemia; Insulin; Male; Middle Aged; Time Factors

1972
[Loading-test with arginine in Huntington's chorea].
    Humangenetik, 1969, Volume: 7, Issue:3

    Topics: Adult; Arginine; Chromatography, Ion Exchange; Female; Humans; Huntington Disease; Male; Middle Aged

1969